Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Karyopharm Therapeutics ( (KPTI) ) has issued an update.
On February 27, 2026, Karyopharm Therapeutics Inc. amended its existing Credit and Guaranty Agreement to reduce near-term cash outflows and extend its liquidity runway beyond the second quarter of 2026, aligning with the anticipated mid-2026 readout of top-line data from its Phase 3 XPORT-EC 042 trial. The Second Amendment allows deferral of certain principal and interest payments to September 2026, maintains a $10 million minimum liquidity covenant through October 10, 2026, and prevents specified equity raise proceeds from increasing that covenant, while also extending a 5% prepayment premium window if a qualifying $25 million capital raise is completed before June 10, 2026.
The most recent analyst rating on (KPTI) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on Karyopharm Therapeutics stock, see the KPTI Stock Forecast page.
Spark’s Take on KPTI Stock
According to Spark, TipRanks’ AI Analyst, KPTI is a Neutral.
Overall score is held down primarily by weak financial performance (persistent losses, negative equity, and continued cash burn with a tight runway). Offsetting factors include strong technical uptrend signals and a catalyst-heavy 2026 setup from upcoming Phase III readouts and guided revenue, though valuation is difficult to assess with negative earnings and no stated dividend yield.
To see Spark’s full report on KPTI stock, click here.
More about Karyopharm Therapeutics
Karyopharm Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies, including late-stage clinical candidates such as those evaluated in the Phase 3 XPORT-EC 042 trial. The company’s market focus centers on advancing event-driven oncology studies and managing its capital structure to support ongoing research and development.
Average Trading Volume: 474,266
Technical Sentiment Signal: Hold
Current Market Cap: $175.9M
For a thorough assessment of KPTI stock, go to TipRanks’ Stock Analysis page.